Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Body composition and metabolic manifestations of insulin resistance in adolescents with polycystic ovary syndrome: Ectopic fat deposition and metabolic markers - baseline study
Body composition and metabolic manifestations of PCOS
Sponsor:Division of Pediatric Endocrinology
Enrolling:Female Patients Only
Study Length:1 Days
Clinic Visits:1
Age Range:Between 13 and 21 years old
IRB Number:AAAA7793
U.S. Government ID:NCT02506946
Contact: Claire Burghard: 212-305-1518 /
Additional Study Information:

Polycystic ovary syndrome (PCOS) is a common disorder. Young women with PCOS have irregular or absence of menstruation and excessive acne and or hair on their bodies. They may have multiple cysts on their ovaries. Adolescents and women affected with PCOS are at risk of developing abnormalities in their blood including high fat, low HDL cholesterol (good cholesterol), high blood pressure and prediabetes or diabetes; they also have increased fat in the abdominal area. This cluster of abnormalities is called the metabolic syndrome. Currently, there are no established markers to identify which adolescents or young adults with PCOS who may develop the metabolic syndrome. Specific body fat distribution patterns, fat in muscles the liver and pancreas are associated with metabolic abnormalities. Young women with PCOS also may have lower bone mineral density than unaffected young women. This has never, to our knowledge, been investigated in adolescents with PCOS. Some young women with PCOS have insulin resistance. This means that their body needs to produce more insulin in order to keep their blood sugar at a normal level. Early signs of insulin resistance include accumulation of fat in the muscle, liver, pancreas and trunk. Metformin is a medication that is used to treat insulin resistance in adolescents with PCOS. The following groups are eligible for this study: 1. Adolescent girls (13-21 years) with PCOS who started menstruating at least two years prior to enrollment; 2. Healthy adolescent girls (13-21 years) without PCOS

Do You Qualify?
Are you an adolescent girl/young woman between the ages of 13 and 21?YesNo
Do you take any hormonal mediacations including oral contraception?YesNo
Do you take metformin or other insulin sensitizing medications?YesNo
Do you take any steroidal anti-inflammatory medications?YesNo
Did you start getting your period at least 2 years ago?YesNo
Aviva Sopher, MD, MS
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Claire Burghard
Phone: 212-305-1518